Their paper entitled Nuclear DNA and Mitochondrial Damage of the Cooked Meat Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Human Neuroblastoma Cells was selected as a Paper of the Month in September 2023.
Lichtenfels was named a Leader in the Promotion of Diversity, Equity, Inclusion, and Respect by the American Chemical Society (ACS).
Hood will start July 10; brings strong financial and strategic background
Robert Vince, PhD, director of the Center for Drug Design at the University of Minnesota, has been selected as the 2022 Lawrence C. and Delores M. Weaver Medal recipient.
Over the past decades we have learned that cancer is a very complex disease. There are many forms of cancer arising from organ specific malignancies that can further metastasize to other organs. Tumors themselves are now recognized to not just be one type of cell but a community of many different types of cells, including many types of tumor cells. Key among these cells are what are being called cancer stem cell like cells or CSCs.
Dr. Karunya Kandimalla has been selected as the new associate dean of graduate education for the University of Minnesota College of Pharmacy.
High-throughput screening is a reliable method for discovering compounds that interact with novel therapeutic targets to improve human health. “Nuisance compounds” interfere with drug discovery by confounding screening results.
Mycobacterium abscessus is an opportunistic pathogen that causes severe lung infections, particularly in patients with underlying lung disorders such as cystic fibrosis or chronic pulmonary disease and is intrinsically resistant to most antibiotics. The high pH in the airway lumen environment serves as a natural barrier, in
Recognizes connections to Minnesota and College of Pharmacy as influential